Abstract
Resveratrol (3,5,4'-trans-trihydroxystilbene) is a naturally occurring phytoalexin that is found in medicinal plants, grape skin, peanuts and red wine. Resveratrol exhibits a remarkable range of biological activities, including anticancer activity, antitubulin activity, anti-cardiovascular disease activity, etc. Several other natural products are structurally similar to resveratrol and also present in food. In addition, a series of resveratrol derivatives have been synthesized by the addition of defined functional groups to increase the potency or enhance the activity of specific properties of resveratrol. These resveratrol derivatives might provide promising functions as cardiovascular disease chemopreventive agents. In this review, we will attempt to summarize the main developments of resveratrol derivatives in cardiovascular disease and the main developments have occurred in derivatives of resveratrol’s structure-activity relationship and cardiovascular disease over the last couple of decades.
Keywords: Cardiovascular disease, reactive oxygen species, apoptosis, SIRT1, AMPK, Akt, derivatives of resveratrol, structure-activity relationship, structure-activity, relationship, phytoalexin.
Current Medicinal Chemistry
Title:Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease
Volume: 19 Issue: 24
Author(s): Ban-Feng Ruan, Xiao-Qin Lu, Jie Song and Hai-Liang Zhu
Affiliation:
- State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, P. R. China.,China
Keywords: Cardiovascular disease, reactive oxygen species, apoptosis, SIRT1, AMPK, Akt, derivatives of resveratrol, structure-activity relationship, structure-activity, relationship, phytoalexin.
Abstract: Resveratrol (3,5,4'-trans-trihydroxystilbene) is a naturally occurring phytoalexin that is found in medicinal plants, grape skin, peanuts and red wine. Resveratrol exhibits a remarkable range of biological activities, including anticancer activity, antitubulin activity, anti-cardiovascular disease activity, etc. Several other natural products are structurally similar to resveratrol and also present in food. In addition, a series of resveratrol derivatives have been synthesized by the addition of defined functional groups to increase the potency or enhance the activity of specific properties of resveratrol. These resveratrol derivatives might provide promising functions as cardiovascular disease chemopreventive agents. In this review, we will attempt to summarize the main developments of resveratrol derivatives in cardiovascular disease and the main developments have occurred in derivatives of resveratrol’s structure-activity relationship and cardiovascular disease over the last couple of decades.
Export Options
About this article
Cite this article as:
Ruan Ban-Feng, Lu Xiao-Qin, Song Jie and Zhu Hai-Liang, Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease, Current Medicinal Chemistry 2012; 19(24) . https://dx.doi.org/10.2174/092986712802430054
| DOI https://dx.doi.org/10.2174/092986712802430054 |
Print ISSN 0929-8673 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Allegations from Whistleblowers
- Publishing Ethics
- Increase Visibility Of Your Article
- Self Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Phenotypic Screening for Pharmaceuticals Using Tissue Constructs
Current Pharmaceutical Biotechnology Atrial Natriuretic Peptide: Structure, Function, and Physiological Effects: A Narrative Review
Current Cardiology Reviews Regulative Roles of Ghrelin in Ingestive Behavior, Upper Gastrointestinal Motility, and Secretion
Current Nutrition & Food Science Phytochemical Therapies in Vascular Functioning: A Molecular Approach
Current Vascular Pharmacology An Emerging Antiarrhythmic Target: Late Sodium Current
Current Pharmaceutical Design Diabetic Retinopathy and Atherosclerosis: is there a Link?
Current Diabetes Reviews Puerarin: A Review on the Pharmacological Activity, Chemical Properties and Pharmacokinetics of Main Isoflavonoid
The Natural Products Journal Transposable Elements in Cancer and Other Human Diseases
Current Cancer Drug Targets The Clinical Problems of Hypertension Treatment in Hemodialysis Patients
Current Vascular Pharmacology Molecular Aspects of Modulation of L-type Calcium Channels by Protein Kinase C
Current Molecular Pharmacology Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
Coronaviruses Cryoballoon Ablation for the Treatment of Atrial Fibrillation: A Meta-analysis
Current Cardiology Reviews PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Cardiovascular disease management through restrained inflammatory responses
Current Pharmaceutical Design Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets Caveolin-3: Its Importance in Muscle Function and Pathology
Current Genomics Cord Blood as Diagnostic Window for Preeclampsia
Recent Patents on Biomarkers The Hellp Syndrome: A Review
Current Women`s Health Reviews G Protein-Coupled Receptors – Potential Roles in Clinical Pharmacology
Cardiovascular & Hematological Agents in Medicinal Chemistry

